Overview


According to FutureWise analysis the market for alopecia in 2023 is US$ 8.96 billion, and is expected to reach US$ 10.66 billion by 2031 at a CAGR of 9.20%.

Alopecia areata is a condition in which the immune system destroys hair follicles, resulting in hair loss. Hair follicles are skin structures that produce hair. While hair loss can occur everywhere on the body, alopecia areata most commonly affects the head and face. Hair normally comes out in small, circular patches about the size of a quarter, but hair loss can be more severe in certain situations. Most individuals with the condition are healthy and have no other symptoms. Alopecia areata progresses differently in each individual. Some individuals experience hair loss episodes throughout their lives, while others only have one. Recovery is also unpredictable, with some patients experiencing complete hair regrowth while others do not. There is no cure for alopecia areata; however, there are treatments that can help hair regrow faster. There are various resources available to assist people in dealing with hair loss.

Alopecia, or hair loss, encompasses various forms, each with distinct causes and characteristics. The most common type is Androgenetic Alopecia, also known as male or female pattern baldness, which is hereditary and leads to hair thinning and loss predominantly on the crown and temples in men and diffuse thinning in women. Another form is Alopecia Areata, an autoimmune disorder where the immune system unknowingly attacks hair follicles, resulting in sudden hair loss in patches and, in severe cases, total baldness (alopecia totalis) or complete loss of body hair (alopecia universalis). Telogen Effluvium, a temporary condition, occurs due to stress, illness, or medication, causing excessive shedding as hair follicles enter a resting phase. Lastly, Traction Alopecia arises from repeated tension on the hair due to tight hairstyles like braids or ponytails, leading to hair loss around the hairline and temples. Each type of alopecia requires specific treatments, making it vital to consult a healthcare professional or dermatologist for accurate diagnosis and appropriate management.

FutureWise Market Research has published a report that provides an insightful analysis of alopecia market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the alopecia market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Johnson and Johnson Services, Inc.
  • MerckCo. Inc.
  • Cipla Limited
  • Sun Pharmaceuticals Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc.
  • Aurobindo Pharma
  • Mylan N.V. (Viatris Inc.)

(Note: The list of the major players will be updated with the latest market scenario and trends)

The alopecia market has experienced significant growth due to several driving factors, with increasing awareness of alopecia as a primary contributor. As individuals are becoming more conscious of their appearance and the impact of hair loss on their self-esteem and quality of life, there is a growing demand for effective solutions to address this concern. This rising awareness has led to a shift in societal attitudes, with more individuals seeking medical help and exploring various treatment options for hair loss. Furthermore, the prevalence of hair loss has been on the rise globally. Factors such as changing lifestyles, increasing stress levels, environmental pollution, and genetic predisposition have contributed to the growing incidence of alopecia. As the number of affected individuals increases, the demand for treatments and therapies to manage hair loss also rises, propelling the growth of the Alopecia market. Moreover, technological advancements in alopecia treatment have played a crucial role in driving market growth. The continuous development of innovative therapies and medical procedures has led to more effective and targeted solutions for different types of alopecia. Advancements in hair transplant techniques, the discovery of novel drugs, and the emergence of personalized treatments have significantly improved the outcomes for patients suffering from hair loss conditions. Moreover, the growing acceptance of cosmetic procedures and hair restoration therapies has played a role in the market's expansion. With the advent of minimally invasive and non-surgical hair restoration techniques, more individuals are willing to consider these treatments as viable options to address their hair loss concerns which are expected to slate opportunities for key players to generate revenue for this target market. However, some of the advanced and more effective treatments for alopecia are costly, making them inaccessible to a prominent portion of the population, particularly in lower-income regions. The high cost of treatment may create disparities in access to care and limit treatment options for many individuals, limiting market growth.

By Disease Type

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Androgenetic Alopecia
  • Others

By Treatment

  • Pharmaceuticals
  • Devices

By Gender

  • Male
  • Female

By Sales Channel

  • Prescriptions
  • OTC

By End Use

  • Dermatology Clinics
  • Homecare Settings

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. due to the disease's high incidence, improved consumer awareness, proactive government initiatives, advances in healthcare infrastructure, and technological breakthroughs in the area. Furthermore, the growing use of laser-based therapy to treat alopecia has contributed to an increase in treatment rates in North America. In addition, the presence of government and non-profit organizations such as the National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and others provides guidelines and raises public awareness, which is likely to benefit the industry. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Alopecia Market By Disease Type, By Treatment, By Gender, By Sales Channel, By End Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Alopecia Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alopecia Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Alopecia Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Alopecia Market, By Disease Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alopecia Areata
        2. Cicatricial Alopecia
        3. Traction Alopecia
        4. Alopecia Totalis
        5. Alopecia Universalis
        6. Androgenetic Alopecia
        7. Others

  • 8.   Global Alopecia Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceuticals
        2. Devices

  • 9.   Global Alopecia Market, By Gender Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Male
        2. Female

  • 10.   Global Alopecia Market, By Sales Channels Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prescriptions
        2. OTC

  • 11.   Global Alopecia Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dermatology Clinics
        2. Homecare Settings

  • 12.   North America Alopecia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Alopecia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Alopecia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Alopecia Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •       1. Johnson & Johnson Services, Inc.
               1.1. Company Overview
               1.2. Product Portfolio
               1.3. SWOT Analysis
               1.4. Financial Overview
               1.5. Strategic Overview
            2. Merck & Co. Inc.
               2.1. Company Overview
               2.2. Product Portfolio
               2.3. SWOT Analysis
               2.4. Financial Overview
               2.5. Strategic Overview
            3. Cipla Limited
               3.1. Company Overview
               3.2. Product Portfolio
               3.3. SWOT Analysis
               3.4. Financial Overview
               3.5. Strategic Overview
            4. Sun Pharmaceuticals Industries Ltd.
               4.1. Company Overview
               4.2. Product Portfolio
               4.3. SWOT Analysis
               4.4. Financial Overview
               4.5. Strategic Overview
            5. Dr. Reddy's Laboratories Ltd.
               5.1. Company Overview
               5.2. Product Portfolio
               5.3. SWOT Analysis
               5.4. Financial Overview
               5.5. Strategic Overview          
            6. GlaxoSmithKline plc.
               6.1. Company Overview
               6.2. Product Portfolio
               6.3. SWOT Analysis
               6.4. Financial Overview
               6.5. Strategic Overview
            7. Aurobindo Pharma
               7.1. Company Overview
               7.2. Product Portfolio
               7.3. SWOT Analysis
               7.4. Financial Overview
               7.5. Strategic Overview
            8. Mylan N.V. (Viatris Inc.)
               8.1. Company Overview
               8.2. Product Portfolio
               8.3. SWOT Analysis
               8.4. Financial Overview
               8.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

Alopecia Treatment Market

Read More

Alopecia Areata Market

Read More
Partner

Our Clients